Immediate Release Technology (IRT), developed and patented by APR, is characterized by the unique blending of excipients and in particular a special ratio between diclofenac and bicarbonate, that create a micro-environmental at gastro-intestinal level, to ensure more rapid and regular absorption and faster onset of action of diclofenac in APR formulations (powder for oral solution, tablets and oral solution) compared with conventional preparations.